Waters Corp. merges with BD’s Biosciences & Diagnostic Solutions
New England Council member, Waters Corporation, has recently announced its combination with Becton, Dickinson and Co.’s (BD) Biosciences & Diagnostic Solutions business, a $17.5 billion transaction. The merger is expected to increase the company’s total sales significantly. This year’s sales are projected to exceed $6 billion for the combined company, while sales for 2024 are expected to total around $3 billion.
“We are bringing together two pioneering organizations with a rich history of delivering breakthrough innovations driven by strong R&D investment and a common customer-centric culture,” said Waters’ CEO, Udit Batra.
Waters, a Milford-based lab instrument and software company, employs more than 1,500 workers. The merger with BD is expected to be finalized by the first quarter of 2026. Batra added that the deal is expected to increase the company’s total market value to approximately $40 billion.
The New England Council congratulates Waters Corp. on this new development.
Read more via The Boston Globe or Boston Business Journal.